Events/N
Median (months)
Subgroup
Eribulin
Cape
HR (95% CI)
Eribulin Cape
Overall
446/554 459/548
0.879 (0.770, 1.003)
15.9
14.5
ER Status
Positive
198/259 219/278
0.897 (0.737, 1.093)
18.2
16.8
Negative
196/233 199/216
0.779 (0.635, 0.955)
14.4
10.5
Not Done
52/62
41/54
1.135 (0.738, 1.747)
17.6
20.4
PR Status
Positive
173/227 185/234
0.850 (0.684, 1.055)
18.1
16.2
Negative
219/262 223/248
0.849 (0.701, 1.029)
14.5
12.0
Not Done
54/65
51/66
1.111 (0.738, 1.670)
17.9
19.1
Triple-negative patients
Yes
124/150 121/134
0.702 (0.545, 0.906)
14.4
9.4
No
322/404 338/414
0.927 (0.795, 1.081)
17.5
16.6
Study 301: Overall Survival by Receptor Status
ITT Population.
0.2
0.5
1.0
2
5
